Genmab — Juli 2018
-
God morgen
-
this shows that the JNJ-63723283 - Dara study that was halted had only enrolled 10 patients https://clinicaltrials.gov/ct2/history/NCT03357952?A=7&B=8&C=merged
-
the (D-RVd) vs (RVd) is now set to an actual recruitment of 224 https://clinicaltrials.gov/ct2/history/NCT02874742?A=24&B=25&C=merged
-
this atezolizumab for MM trial was also updated https://clinicaltrials.gov/ct2/history/NCT02431208?A=39&B=40&C=merged
-
ah sorry, i thought i posted the NSCLC last Friday, thx
https://clinicaltrials.gov/ct2/history/NCT03023423?A=20&B=21&C=merged -
Lonial Lays Out Optimal Sequence Strategies for Relapsed/Refractory Myeloma https://www.onclive.com/conference-coverage/pplc-2018/lonial-lays-out-optimal-sequence-strategies-for-relapsedrefractory-myeloma
-
Revolutionizing MM treatment with daratumumab http://www.oncologytube.com/video/revolutionizing-mm-treatment-with-daratumumab/10004677
-
this one I think we have seen, but since it is Agurketid
Subcutaneous daratumumab: an update on the latest MM clinical trials http://www.oncologytube.com/video/subcutaneous-daratumumab-an-update-on-the-latest-mm-clinical-trials/10004685 -
God morgen
-
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind